News in English
Декабрь
2024
19
20
21
22
23
24
25
26
27
28
29
30
31

Новости за 17.12.2024

BigNewsNetwork.com (sports) 

Backup QB guides Tulane into Gasparilla Bowl vs. Florida

(Photo credit: Matthew Hinton-Imagn Images) Florida wasn't always sure it was going to win enough games to become bowl-eligible. Tulane flirted with the possibility of playing its way into the College Football Playoff. Eventually a late-season surge by the Gators (7-5) and consecutive losses by the Green Wave (9-4) landed them both in the Gasparilla Bowl on Friday in Tampa. Florida, which failed to make a bowl game at

Economictimes.indiatimes.com 

NEET in online or pen and paper mode: Decision expected soon, says Pradhan

India's medical entrance exam, NEET-UG, might go digital. The Education and Health Ministries are evaluating online versus offline modes. A final decision will impact over 24 lakh aspirants. The National Testing Agency is prepared for either format. Changes will apply to the 2025 exam. This follows concerns over exam security and potential leaks.

Economictimes.indiatimes.com 

NCERT textbooks to cost less from 2025, new books for classes 9-12 by 2026: Dharmendra Pradhan

The National Council of Educational Research and Training (NCERT) will increase textbook production from 5 crore to 15 crore next year, leading to lower prices for some classes. Education Minister Dharmendra Pradhan assured no price hikes for any class. Updated textbooks aligned with the new National Curriculum Framework will be available for classes 9-12 by the 2026-27 academic session.

Football LineUps 

Spain - Almeria vs Leganes

Segunda División 2015/2016 - Matchday 1 - Played 23-Aug-15 - Posted by israel gonzalez

Economictimes.indiatimes.com 

Stock To Buy Today: Brokerages initiate coverage on Afcons Infrastructure & Piramal Pharma

Brokerage firms are bullish on Afcons Infrastructure, Delhivery, and Piramal Pharma, projecting significant upside potential. Investec, Equirus, and JM Financial have initiated coverage with buy ratings, citing strong growth prospects, robust financials, and attractive valuations. These companies are poised for substantial gains, driven by infrastructure development, e-commerce growth, and pharmaceutical sector expansion.